careers in the sciences: healthcare, labs & Research

Mark A. Ware

Artsci’86 (philosophy and Biochemistry)

MSc Chief Medical Officer (CMO), Canopy Growth Corporation

Since joining Canopy Growth in July 2018, Dr. Ware has helped establish the Company’s global medical division, Spectrum Therapeutics, and led the team responsible for the supply and regulatory documentation, clinical development, medical affairs, and global product safety. As CMO, Dr. Ware advises on scientific and ethical aspects of Canopy Growth’s global research efforts and is responsible for the Company’s pharmacovigilance safety program encompassing all R&D and commercial activities.  

Before joining Canopy Growth, Dr. Ware was a tenured associate professor in the Faculty of Medicine at McGill University. Following undergraduate studies in biochemistry and philosophy at Queen’s University, he obtained his medical degree at the University of the West Indies, undertook postgraduate training in internal medicine, and secured a Master’s degree in epidemiology from the London School of Hygiene and Tropical Medicine. He began evaluating the role of cannabis in pain management at McGill University in 1999, where he served as Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre for over 10 years. He was the co-founder of the non-profit Canadian Consortium for the Investigation of Cannabinoids and served as Executive Director from 2007 to 2018. He has advised the Canadian federal government on cannabis policy since 2001, and in 2016, he served as the vice-chair of the Federal Task Force on the Legalization and Regulation of Cannabis in Canada. He has over 100 publications on cannabis and pain in peer-reviewed journals and has spoken widely and national and international conferences on cannabis in medicine. 

Joanne Langley

Artsci’79 (Politics)

Pediatric Infectious Disease Physician, IWK Health Centre

Dr. Langley is a pediatric infectious disease physician in the Department of Pediatrics and is cross-appointed in the Department of Community Health and Epidemiology in the Faculty of Medicine at Dalhousie University. She is based at the IWK Health Centre and the Canadian Centre for Vaccinology. She conducts studies on the prevention of infectious diseases using vaccines, from phase 1 (first in humans) through to efficacy trials (phase 3) and post-marketing studies of how well vaccines work when they are used in immunization programs (phase 4). These studies are done with collaborators in public health, industry, universities, and non-governmental organizations.

Dr. Langley’s work also focuses on vaccine policy and evidence-based decision making in immunization programs. She is a member of the COVID-19 Science Expert Panel, and the Expert Group on Health Systems of the Chief Science Advisor of Canada, and a former member of the Canadian Task Force on Preventive Health Care and Canada’s National Advisory Committee on Immunization (Chair, 2007-2011). She is an active investigator in the Canadian Immunization Research Network and leads its Clinical Trials Network (CTN). 

Anton Toutov

Artsci’11 (Chemistry)

Founder & CSO Fuzionaire Diagnostics

Anton is the Founder and Chief Science Officer at Fuzionaire and Fuzionaire Diagnostics — VC-funded chem-tech start-ups with operations in the US, Canada, and Japan. His other appointments include Senior Technical Adviser to the Gates Foundation-backed Medicines for All Institute (M4All); Co-Founder of Astra Navigation; Assistant Professor (by courtesy) at Virginia Commonwealth University (VCU); Chairperson of the Queen’s DDQIC-GN: Los Angeles; and IAB member at the Queen’s Chemistry Innovation Council (QCIC).

A scientist-entrepreneur, Anton’s PhD thesis in chemistry was awarded Caltech’s Entrepreneurship Prize in 2016, was the subject of the Resnick Institute short documentary film Element 19, and has been spotlighted by Nature magazine, NASA, Scientific American, The UK Royal Society, the NSF, and others. He has written for Wired, TNW, The Conversation, and other mainstream outlets on a variety of topics including drug discovery, quantum computing, nuclear medicine, emissions control, magnetoreception, and immunology.

Anton has authored 10 peer-reviewed scholarly publications in top-tier journals and is an inventor on over 60 patent grants and applications in the chemical sciences. He holds a BSc from Queen’s (ArtSci ’11) and a Ph.D. in organic chemistry from Caltech, working in the lab of Nobel Laureate Bob Grubbs.  

Darlene Lim

Artsci’94 (Biology)

Research scientist, NASA Ames Research Center

Dr. Darlene Lim is a research scientist at the NASA Ames Research Center. She is the Deputy Project Scientist for the NASA VIPER Lunar Rover Mission and also leads several NASA-funded research programs that are focused on blending field science with the development of capabilities and concepts for human-robotic spaceflight to the Moon and Mars. She is the Principal Investigator of the SUBSEA, BASALT, and Pavilion Lake research programs, Deputy PI for FINESSE, and Science Ops lead for RESOURCE.

Darlene has conducted field research around the world, on land and underwater. She has served on several NASA Mars Exploration Program Analysis Group committees and is currently serving on the NOAA Ocean Exploration Advisory Board and the NASA Network for Ocean Worlds Steering Committee.  Her fondest Queen’s memories are meeting her husband and attending limnology lectures by Dr. John Smol.

 For more details, check out www.darlenelimology.com